Musa Yilmaz Selected Research

Musa Yilmaz Research Topics

Disease

27	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 09/2015
10	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 10/2015
7	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2022 - 12/2013
7	Philadelphia Chromosome 01/2022 - 01/2018
5	Leukemia 11/2022 - 01/2019
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2022 - 01/2019
3	Disease Progression 05/2022 - 03/2018
3	Neoplasms (Cancer) 01/2021 - 01/2019
2	Infertility (Sterility) 07/2022 - 10/2015
2	Acute Promyelocytic Leukemia 01/2022 - 01/2019
2	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2018
2	Primary Myelofibrosis (Myelosclerosis) 01/2022 - 01/2019
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2021 - 01/2019
2	Infections 08/2021 - 01/2018
2	Pleural Effusion (Pleural Effusions) 01/2020 - 01/2018
2	Myocardial Infarction 08/2014 - 06/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2014 - 01/2014
2	Obesity 07/2014 - 01/2014
1	Febrile Neutropenia 08/2021
1	Blast Crisis (Blast Phase) 01/2021
1	Cytopenia 01/2020
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019
1	Splenomegaly 01/2019
1	Anemia 01/2019
1	Pathologic Complete Response 01/2019
1	Systemic Scleroderma (Systemic Sclerosis) 11/2017
1	Fibrosis (Cirrhosis) 11/2017
1	Acute Coronary Syndrome 01/2017
1	Hemolysis 02/2016

Drug/Important Bio-Agent (IBA)

19	venetoclaxIBA 05/2022 - 01/2019
7	Tyrosine Kinase InhibitorsIBA 05/2022 - 11/2015
7	Decitabine FDA Link 12/2021 - 01/2021
5	Inotuzumab OzogamicinIBA 01/2022 - 10/2015
4	blinatumomabIBA 01/2022 - 01/2018
4	Dasatinib (BMS 354825)FDA Link 01/2020 - 11/2015
3	fms-Like Tyrosine Kinase 3IBA 01/2022 - 01/2019
3	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 12/2013
2	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2022 - 08/2021
2	ponatinibIBA 05/2022 - 01/2021
2	ruxolitinibIBA 01/2022 - 01/2019
2	ibrutinibIBA 08/2021 - 01/2019
2	Arsenic Trioxide (Trisenox)FDA Link 01/2021 - 01/2019
2	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 12/2015
2	Sorafenib (BAY 43-9006)FDA Link 11/2019 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 07/2019 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2019
2	GhrelinIBA 10/2015 - 06/2013
2	LeptinIBA 10/2015 - 06/2013
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 08/2014 - 06/2014
2	FructoseIBA 07/2014 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 06/2014 - 01/2014
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 07/2022
1	AnthracyclinesIBA 05/2022
1	purineIBA 05/2022
1	AndrogensIBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	enasidenibIBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	Immunomodulating AgentsIBA 01/2022
1	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 01/2022
1	gilteritinibIBA 01/2022
1	fedratinibIBA 01/2022
1	Azacitidine (5 Azacytidine)FDA Link 01/2022
1	SteroidsIBA 01/2022
1	Alanine Transaminase (SGPT)IBA 08/2021
1	Cladribine FDA LinkGeneric 08/2021
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 08/2021
1	isavuconazoleIBA 01/2021
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2021
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021
1	Retinoic Acid Receptor alphaIBA 01/2021
1	AntibodiesIBA 12/2020
1	AntigensIBA 12/2020
1	Bispecific AntibodiesIBA 12/2020
1	Drug CombinationsIBA 01/2020
1	Vincristine (Oncovin)FDA LinkGeneric 01/2020
1	bcr-abl Fusion ProteinsIBA 01/2020
1	midostaurinIBA 11/2019
1	Janus Kinase 2IBA 01/2019
1	DioxygenasesIBA 01/2019
1	MethyltransferasesIBA 01/2019
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2019
1	SB939 compoundIBA 01/2019
1	Transaminases (Aminotransferases)IBA 01/2018
1	OsteopontinIBA 11/2017
1	VitronectinIBA 11/2017
1	EnzymesIBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2016

Therapy/Procedure

23	Drug Therapy (Chemotherapy) 11/2022 - 10/2015
18	Therapeutics 01/2022 - 10/2015
3	Induction Chemotherapy 01/2022 - 09/2015
3	Salvage Therapy 01/2021 - 09/2015
3	Drug Tapering 01/2020 - 01/2018
2	Consolidation Chemotherapy 01/2020 - 01/2018
1	Transplantation 05/2022
1	Remission Induction 01/2021
1	Radiotherapy 01/2020
1	Combination Drug Therapy (Combination Chemotherapy) 01/2019